[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].

Hypercalcemia of malignancy is a common problem for cancer clinicians. Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer is reported herein. The patient was a 36-year-old man who had neck lymph node metastases due to recurrence of squamous cell carcinoma of the buccal mucosa and complained of cloudiness of consciousness due to hypercalcemia. The patient was administered pamidronate. A fine reduction in serum calcium was observed and cloudiness of consciousness was also alleviated. Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life.
AuthorsNorihiko Nishimura, Yuki Matsushita, Kazuki Takaoka, Susumu Hashitani, Kazuma Noguchi, Masahiro Urade
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 29 Issue 13 Pg. 2537-9 (Dec 2002) ISSN: 0385-0684 [Print] Japan
PMID12506478 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Diphosphonates
  • pamidronate
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, pathology, secondary)
  • Consciousness Disorders (etiology)
  • Diphosphonates (therapeutic use)
  • Drug Administration Schedule
  • Humans
  • Hypercalcemia (drug therapy, etiology)
  • Lymphatic Metastasis
  • Male
  • Mouth Neoplasms (drug therapy, pathology, psychology)
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: